Tag Archives: NSCLC
Combination of Pembrolizumab Plus cCRT Demonstrated Promising Outcomes in Patients with Unresectable, Locally Advanced NSCLC
According to follow up data presented at the International Association for the Study of Lung Cancer 2020 World Conference on […]
ikrisuser
July 15, 2021FDA Granted Approval Of First Companion Diagnostic Test for Expanded EGFR TKIs in NSCLC
According to a press release, Roche (the test developer) announced that, “The Food and Drug Administration has approved the cobas […]
